Trandolapril

• Description:

  Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that is hydrolysed to the active diacid trandolaprilat.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  430.545

• Molecular Formula:

  C24H34N2O5

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  87679-37-6